Ranbaxy Pharmaceuticals Canada Inc. (RPCI) is a wholly
owned subsidiary of Ranbaxy Laboratories Limited (RLL),
India 's largest pharmaceutical company. RPCI is the first
India-based pharmaceutical company to enter the Canadian
market. RPCI is engaged in the sale
and distribution of affordable generic medicines in the
Canadian healthcare system. Ranbaxy's R&D efficiencies
and globally integrated systems enable RPCI to develop and
manufacture pharmaceuticals to be brought to market quickly,
efficiently, and at lower costs. As a result, we anticipate
making a meaningful contribution to the healthcare system
in Canada, as in other countries where we have done business.
Therapeutic Products Directorate (TPD) has already granted
approval to RPCI to market a number of products in Canada.
Management Team
Canadian Management Team is led by a professional
staff with extensive experience and knowledge in meeting
the needs of the Canadian pharmaceutical market, they are:
